chr1-19978469-C-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_001395463.1(PLA2G2A):ā€‹c.96G>Cā€‹(p.Thr32=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0927 in 1,613,622 control chromosomes in the GnomAD database, including 8,138 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: š‘“ 0.078 ( 646 hom., cov: 32)
Exomes š‘“: 0.094 ( 7492 hom. )

Consequence

PLA2G2A
NM_001395463.1 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.98
Variant links:
Genes affected
PLA2G2A (HGNC:9031): (phospholipase A2 group IIA) The protein encoded by this gene is a member of the phospholipase A2 family (PLA2). PLA2s constitute a diverse family of enzymes with respect to sequence, function, localization, and divalent cation requirements. This gene product belongs to group II, which contains secreted form of PLA2, an extracellular enzyme that has a low molecular mass and requires calcium ions for catalysis. It catalyzes the hydrolysis of the sn-2 fatty acid acyl ester bond of phosphoglycerides, releasing free fatty acids and lysophospholipids, and thought to participate in the regulation of the phospholipid metabolism in biomembranes. Several alternatively spliced transcript variants with different 5' UTRs have been found for this gene.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-19978469-C-G is Benign according to our data. Variant chr1-19978469-C-G is described in ClinVar as [Benign]. Clinvar id is 3059119.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.98 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLA2G2ANM_001395463.1 linkuse as main transcriptc.96G>C p.Thr32= synonymous_variant 3/5 ENST00000482011.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLA2G2AENST00000482011.3 linkuse as main transcriptc.96G>C p.Thr32= synonymous_variant 3/51 NM_001395463.1 P1

Frequencies

GnomAD3 genomes
AF:
0.0778
AC:
11828
AN:
152076
Hom.:
650
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0170
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.119
Gnomad EAS
AF:
0.226
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.0973
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.0854
Gnomad OTH
AF:
0.0690
GnomAD3 exomes
AF:
0.109
AC:
27504
AN:
251184
Hom.:
1811
AF XY:
0.109
AC XY:
14777
AN XY:
135766
show subpopulations
Gnomad AFR exome
AF:
0.0161
Gnomad AMR exome
AF:
0.162
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.225
Gnomad SAS exome
AF:
0.120
Gnomad FIN exome
AF:
0.0966
Gnomad NFE exome
AF:
0.0881
Gnomad OTH exome
AF:
0.102
GnomAD4 exome
AF:
0.0943
AC:
137803
AN:
1461428
Hom.:
7492
Cov.:
36
AF XY:
0.0947
AC XY:
68840
AN XY:
727022
show subpopulations
Gnomad4 AFR exome
AF:
0.0140
Gnomad4 AMR exome
AF:
0.156
Gnomad4 ASJ exome
AF:
0.112
Gnomad4 EAS exome
AF:
0.238
Gnomad4 SAS exome
AF:
0.122
Gnomad4 FIN exome
AF:
0.0932
Gnomad4 NFE exome
AF:
0.0863
Gnomad4 OTH exome
AF:
0.0954
GnomAD4 genome
AF:
0.0776
AC:
11817
AN:
152194
Hom.:
646
Cov.:
32
AF XY:
0.0818
AC XY:
6083
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.0169
Gnomad4 AMR
AF:
0.122
Gnomad4 ASJ
AF:
0.119
Gnomad4 EAS
AF:
0.226
Gnomad4 SAS
AF:
0.127
Gnomad4 FIN
AF:
0.0973
Gnomad4 NFE
AF:
0.0854
Gnomad4 OTH
AF:
0.0669
Alfa
AF:
0.0827
Hom.:
153
Bravo
AF:
0.0788
Asia WGS
AF:
0.149
AC:
518
AN:
3476
EpiCase
AF:
0.0839
EpiControl
AF:
0.0887

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PLA2G2A-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 19, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.83
DANN
Benign
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2236771; hg19: chr1-20304962; COSMIC: COSV64287129; API